- About Ash Biotech
- Technology
- Products / Partnering
- Communications
- Contacting Us
Ash Biotech provides advanced automation systems and services to biotechnology and pharmaceutical companies. The company is head-quartered in Cambridge, UK, and undertakes work in the US, Europe and East Asia. We have offerings specifically designed to meet the different needs of start-ups and large organizations.
The company operates a lean business model that allows for extensive gearing of its resources through collaborations with scientists working at larger biotechnology and pharmaceutical companies. Ash Biotech's world-class board and management have several decades of combined drug development and technology development experience, and have been responsible for bringing multiple drugs from discovery to clinical development, including the blockbuster antibody drug, Humira. They also have several "world firsts" in pioneering the development of new technologies used for diverse aspects of drug discovery: for example, high-throughput and ultra-high-throughput antibody drug screening; and high-throughput, high-content screening of model organisms using digital video and computer vision.
The company is unique among automation companies in that it offers genuinely world-class scientific expertise in drug discovery and development (both small-molecule and biologics), combined with a fully-integrated capability in mechatronics (robotics, electronics, mechanical engineering, software and informatics). Whether by using our off-the-shelf products and systems, or through custom project work, Ash Biotech aims to help its partners make major advances in the discovery and development of new drugs; and in the creation of new platform technologies.
The company was initially financed by the founders, and has been profitable since that date through research collaborations with biotechnology and pharmaceutical companies. These revenue streams, along with the deal structures the company has negotiated, have enabled Ash Biotech to: build up world-class IP and know-how in key emerging aspects of drug discovery and development; and fund the development of an innovative new product offering that will enable the commercial exploitation of the company's unique IP and know-how.
The Ash Biotech team has decades of experience in small biotech, big biotech and big pharma; from the lab bench to the board room. Our management team, previously the management team for Technology Division of Cambridge Antibody Technology, is one of the most successful in European biotechnology. The team has played key roles in growing biotech/pharma companies in Europe and the US to a combined value of over two and a half billion dollars.